{"AllianceGenome": "11990", "HGNC": "11990", "MIM": "126431", "_id": "7155", "_version": 1, "accession": {"genomic": ["AC093416.2", "AH006995.2", "AJ011721.1", "AJ011723.1", "AJ011724.1", "AJ011725.1", "AJ011727.1", "AJ011729.1", "AJ011731.1", "AJ011732.1", "CH471055.1", "CP068275.2", "HF583564.1", "NC_000003.12", "NC_060927.1", "NG_052961.1", "U65315.1", "U96765.1", "X71911.1"], "protein": ["AAA61210.1", "AAB01982.1", "AAB54121.1", "AAB95437.1", "AAC77432.1", "AAH21863.1", "BAD92116.1", "BAG59142.1", "BAG59664.1", "BAH14863.1", "CAA09753.1", "CAA37706.1", "CAA48197.1", "CAA50726.1", "CAA78815.1", "CAA78821.1", "CCQ43061.1", "EAW64357.1", "EAW64358.1", "EAW64359.1", "NP_001059.2", "NP_001317629.1", "Q02880.3", "XP_011532359.1", "XP_047304777.1", "XP_047304778.1", "XP_054203683.1", "XP_054203684.1", "XP_054203685.1"], "rna": ["AB208879.1", "AK296510.1", "AK297171.1", "AK307450.1", "AK316492.1", "BC021863.1", "BC054482.1", "BF514624.1", "BM150930.1", "M27504.1", "NM_001068.3", "NM_001330700.2", "U54831.1", "X53662.1", "X68060.1", "XM_011534057.4", "XM_047448821.1", "XM_047448822.1", "XM_054347708.1", "XM_054347709.1", "XM_054347710.1", "Z15111.1", "Z15115.1"], "translation": [{"protein": "AAA61210.1", "rna": "M27504.1"}, {"protein": "NP_001317629.1", "rna": "NM_001330700.2"}, {"protein": "XP_011532359.1", "rna": "XM_011534057.4"}, {"protein": "XP_054203684.1", "rna": "XM_054347709.1"}, {"protein": "CAA37706.1", "rna": "X53662.1"}, {"protein": "NP_001059.2", "rna": "NM_001068.3"}, {"protein": "XP_047304777.1", "rna": "XM_047448821.1"}, {"protein": "BAH14863.1", "rna": "AK316492.1"}, {"protein": "BAG59142.1", "rna": "AK296510.1"}, {"protein": "CAA78821.1", "rna": "Z15115.1"}, {"protein": "XP_054203685.1", "rna": "XM_054347710.1"}, {"protein": "BAG59664.1", "rna": "AK297171.1"}, {"protein": "CAA48197.1", "rna": "X68060.1"}, {"protein": "XP_054203683.1", "rna": "XM_054347708.1"}, {"protein": "XP_047304778.1", "rna": "XM_047448822.1"}, {"protein": "AAH21863.1", "rna": "BC021863.1"}, {"protein": "BAD92116.1", "rna": "AB208879.1"}, {"protein": "AAB01982.1", "rna": "U54831.1"}, {"protein": "CAA78815.1", "rna": "Z15111.1"}]}, "alias": ["BILU", "TOPIIB", "top2beta"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "moderate", "classification_date": "2021-10-19T12:57:36.122Z", "disease_label": "B-cell immunodeficiency, distal limb anomalies, and urogenital malformations", "gcep": "Antibody Deficiencies Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0012243", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_677a64c1-b005-44f6-9846-a7f371222667-2021-10-19T125736.122Z", "sop": "SOP8"}}, "ec": "5.6.2.2", "ensembl": {"gene": "ENSG00000077097", "protein": ["ENSP00000264331", "ENSP00000388216", "ENSP00000391112", "ENSP00000396704", "ENSP00000514096", "ENSP00000514097", "ENSP00000514098"], "transcript": ["ENST00000264331", "ENST00000413971", "ENST00000424225", "ENST00000435706", "ENST00000470132", "ENST00000475717", "ENST00000491510", "ENST00000699028", "ENST00000699029", "ENST00000699030", "ENST00000699031", "ENST00000699032", "ENST00000699033", "ENST00000699034", "ENST00000699035", "ENST00000699036", "ENST00000699037", "ENST00000699038", "ENST00000699039", "ENST00000699040", "ENST00000699041", "ENST00000699042", "ENST00000699043", "ENST00000699044", "ENST00000699045", "ENST00000699046"], "translation": [{"protein": "ENSP00000388216", "rna": "ENST00000413971"}, {"protein": "ENSP00000264331", "rna": "ENST00000264331"}, {"protein": "ENSP00000396704", "rna": "ENST00000435706"}, {"protein": "ENSP00000514096", "rna": "ENST00000699037"}, {"protein": "ENSP00000514097", "rna": "ENST00000699038"}, {"protein": "ENSP00000514098", "rna": "ENST00000699043"}, {"protein": "ENSP00000391112", "rna": "ENST00000424225"}], "type_of_gene": "protein_coding"}, "entrezgene": "7155", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 47.9555573806, "exp_mis": 367.985550246, "exp_syn": 144.174875009, "lof_z": 5.85845478188143, "mis_z": 2.52390551311827, "mu_lof": 4.18085866791e-06, "mu_mis": 4.04248771876e-05, "mu_syn": 1.54797278858e-05, "n_lof": 7.0, "n_mis": 269.0, "n_syn": 166.0, "p_li": 0.99731109311551, "p_null": 1.63912671881142e-12, "p_rec": 0.00268890688285124, "syn_z": -1.12683640881492}, "bp": 4866, "cds_end": 25705788, "cds_start": 25639797, "n_exons": 36, "nonpsych": {"exp_lof": 42.8361238823, "exp_mis": 332.494158954, "exp_syn": 129.923893002, "lof_z": 5.67745244235918, "mis_z": 2.39252563624909, "mu_lof": 4.18085866791e-06, "mu_mis": 4.04248771876e-05, "mu_syn": 1.54797278858e-05, "n_lof": 5.0, "n_mis": 246.0, "n_syn": 152.0, "p_li": 0.999410196685199, "p_null": 1.20893385838907e-12, "p_rec": 0.000589803313591902, "syn_z": -1.21938630443403}, "nontcga": {"exp_lof": 44.0637216319, "exp_mis": 338.491337434, "exp_syn": 132.585499168, "lof_z": 5.6565536272796, "mis_z": 2.8566221859638, "mu_lof": 4.18085866791e-06, "mu_mis": 4.04248771876e-05, "mu_syn": 1.54797278858e-05, "n_lof": 6.0, "n_mis": 233.0, "n_syn": 155.0, "p_li": 0.997871546583815, "p_null": 4.57124047696536e-12, "p_rec": 0.0021284534116139, "syn_z": -1.23254657915856}, "transcript": "ENST00000435706.2"}, "exons": [{"cdsend": 25664297, "cdsstart": 25598306, "chr": "3", "position": [[25597904, 25598477], [25599434, 25599529], [25601099, 25601225], [25604759, 25604870], [25606042, 25606122], [25607170, 25607375], [25609182, 25609344], [25609567, 25609712], [25612514, 25612709], [25615204, 25615288], [25615430, 25615586], [25618417, 25618509], [25618653, 25618849], [25619861, 25620062], [25620681, 25620816], [25623514, 25623746], [25624296, 25624445], [25624681, 25624803], [25626559, 25626674], [25626771, 25626864], [25627186, 25627296], [25628846, 25628952], [25629034, 25629145], [25630028, 25630154], [25630311, 25630469], [25630800, 25630939], [25632445, 25632583], [25632692, 25632794], [25633840, 25634014], [25635935, 25636148], [25637214, 25637312], [25638164, 25638310], [25642321, 25642385], [25643693, 25643784], [25645299, 25645455], [25664228, 25664372]], "strand": -1, "transcript": "NM_001068", "txend": 25664372, "txstart": 25597904}, {"cdsend": 25664297, "cdsstart": 25598306, "chr": "3", "position": [[25597983, 25598477], [25599434, 25599529], [25601099, 25601225], [25604759, 25604870], [25606042, 25606122], [25607170, 25607375], [25609182, 25609344], [25609567, 25609712], [25612514, 25612709], [25615204, 25615288], [25615430, 25615586], [25618417, 25618509], [25618653, 25618849], [25619861, 25620062], [25620681, 25620816], [25623514, 25623746], [25624296, 25624445], [25624681, 25624803], [25626559, 25626674], [25626771, 25626864], [25627186, 25627296], [25628846, 25628952], [25629034, 25629145], [25630028, 25630154], [25630311, 25630469], [25630800, 25630939], [25632445, 25632583], [25632692, 25632794], [25633840, 25634014], [25635935, 25636148], [25637214, 25637312], [25638164, 25638310], [25642321, 25642385], [25643693, 25643784], [25645299, 25645470], [25664228, 25664907]], "strand": -1, "transcript": "NM_001330700", "txend": 25664907, "txstart": 25597983}], "exons_hg19": [{"cdsend": 25705788, "cdsstart": 25639797, "chr": "3", "position": [[25639395, 25639968], [25640925, 25641020], [25642590, 25642716], [25646250, 25646361], [25647533, 25647613], [25648661, 25648866], [25650673, 25650835], [25651058, 25651203], [25654005, 25654200], [25656695, 25656779], [25656921, 25657077], [25659908, 25660000], [25660144, 25660340], [25661352, 25661553], [25662172, 25662307], [25665005, 25665237], [25665787, 25665936], [25666172, 25666294], [25668050, 25668165], [25668262, 25668355], [25668677, 25668787], [25670337, 25670443], [25670525, 25670636], [25671519, 25671645], [25671802, 25671960], [25672291, 25672430], [25673936, 25674074], [25674183, 25674285], [25675331, 25675505], [25677426, 25677639], [25678705, 25678803], [25679655, 25679801], [25683812, 25683876], [25685184, 25685275], [25686790, 25686946], [25705719, 25705863]], "strand": -1, "transcript": "NM_001068", "txend": 25705863, "txstart": 25639395}, {"cdsend": 25705788, "cdsstart": 25639797, "chr": "3", "position": [[25639474, 25639968], [25640925, 25641020], [25642590, 25642716], [25646250, 25646361], [25647533, 25647613], [25648661, 25648866], [25650673, 25650835], [25651058, 25651203], [25654005, 25654200], [25656695, 25656779], [25656921, 25657077], [25659908, 25660000], [25660144, 25660340], [25661352, 25661553], [25662172, 25662307], [25665005, 25665237], [25665787, 25665936], [25666172, 25666294], [25668050, 25668165], [25668262, 25668355], [25668677, 25668787], [25670337, 25670443], [25670525, 25670636], [25671519, 25671645], [25671802, 25671960], [25672291, 25672430], [25673936, 25674074], [25674183, 25674285], [25675331, 25675505], [25677426, 25677639], [25678705, 25678803], [25679655, 25679801], [25683812, 25683876], [25685184, 25685275], [25686790, 25686961], [25705719, 25706398]], "strand": -1, "transcript": "NM_001330700", "txend": 25706398, "txstart": 25639474}], "generif": [{"pubmed": 11927602, "text": "topo II is not an immobile, structural component of the chromosomal scaffold or the interphase karyoskeleton, but rather a dynamic interaction partner of such structures."}, {"pubmed": 12105221, "text": "shows for the first time that topoisomerase II beta is a substrate for PKC zeta, and that PKC zeta may significantly influence topoisomerase II inhibitor-induced cytotoxicity by altering topoisomerase II beta activity through its kinase function"}, {"pubmed": 12197834, "text": "analysis of binding sites for NF-Y and Sp1, which are critical for TOP2B transcription"}, {"pubmed": 12629207, "text": "proteasomal degradation of TOP2beta induced by the TOP2-DNA covalent complex or the TOP2 circular clamp is due to transcriptional arrest but not DNA damage"}, {"pubmed": 12821127, "text": "topoisomerase II is actively exported from the nuclease and is mediated by a CRM1-dependent pathway"}, {"pubmed": 14596941, "text": "demonstrated that neither A or B isoform has any preference for a specific DNA conformation as substrate under the conditions used in these experiments"}, {"pubmed": 14723357, "text": "Topoisomerase II is a potential target for new antilesishmanial drug development."}, {"pubmed": 14996935, "text": "When both topo IIalpha and topo IIbeta were removed, the segregation of chromosomes was severely arrested, suggesting that topo IIbeta could partially substitute for topo IIalpha."}, {"pubmed": 15044480, "text": "UVA-modified DNA is preferentially targeted and processed by topoisomerase IIalpha and IIbeta."}, {"pubmed": 15680922, "text": "This is the first report that conjugated PUFA such as cEPA act as inhibitors of pols and topos."}, {"pubmed": 16091284, "text": "Further analysis of purified virus showed that HIV-1 virion contained topoisomerase II isoform-specific kinase activities, which were partially isolated"}, {"pubmed": 16502015, "text": "TOP2A may have a role in response to doxorubicin-based chemotherapy"}, {"pubmed": 16712776, "text": "Topoisomerase II alpha and beta isoforms are present in the pre-integration complexes, suggesting their significant role in HIV-1 replication."}, {"pubmed": 16794079, "text": "reported that signal-dependent activation of gene transcription by nuclear receptors and other classes of transcription factors requires DNA topoisomerase IIbeta-dependent, transient, site-specific dsDNA break formation"}, {"pubmed": 16932348, "text": "Reduced expression of topo IIbeta induces apoptosis in part by impairing the anti-oxidant capacity of the cell owing to downregulation of PRDX2."}, {"pubmed": 16969495, "text": "EGF may have a role in drug resistance in cultured tumor cells through the downregulation of topoII"}, {"pubmed": 17182034, "text": "We conclude that topo II alpha and beta nuclear export is inhibited in proliferating cells so that these proteins do not shuttle."}, {"pubmed": 17209120, "text": "directed mutation of TOP2B demonstrated missense mutations selected for acridine resistance varied with acridine structure"}, {"pubmed": 17361331, "text": "Topo IIalpha and beta mRNA expression, but not the Topo IIalpha labeling index, might be a useful marker for sensitivity to etoposide in human malignant neuroepithelial tumors."}, {"pubmed": 17526531, "text": "The C-terminal region of human topoisomerase II beta determines its isoform-specific functions in proliferating cells."}, {"pubmed": 18212063, "text": "TopoIIbeta binds a retinoic acid response element. Inhibition causes hyperacetylation of histone 3 at lysine 9 & transcription activation.Increased levels of & association with TopoIIbeta cause resistance to RA in acute promyelocytic leukemia cell lines."}, {"pubmed": 19181665, "text": "NRF-1 can also directly interact with poly(ADP-ribose) polymerase 1 (PARP-1) and co-purify the PARP-1.DNA-PK.Ku80.Ku70.topoisomerase IIbeta-containing protein complex."}, {"pubmed": 19222228, "text": "Data show a difference in metal ion utilization during DNA cleavage mediated by human topoisomerase IIalpha and IIbeta."}, {"pubmed": 19902255, "text": "Data show significant associations between SNPs in RARA, RARB, TOP2B and RARG, RXRA, TLR3, TRIM5 and RIG-I genes and rubella virus-specific cytokine immune responses."}, {"pubmed": 19902255, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20201926, "text": "Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20800603, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20882068, "text": "[review] Accumulating studies show the significant role of Top IIbeta in neuronal development through regulating expression of certain genes in cells committed to the neuronal fate after the final division."}, {"pubmed": 21280220, "text": "Tyrosine 656 in topoisomerase II beta is important for the catalytic activity of the enzyme."}, {"pubmed": 21542140, "text": "Overexpression of Lewis(y) antigen confers cell adhesion-mediated drug resistance to apoptosis in ovarian cancer cells by the upregulation of Topo-I and Topo-II beta."}, {"pubmed": 21793937, "text": "results suggest that the low expression of TOPOIIbeta in patients with tongue carcinoma indicates that intrinsic drug resistance may exist in tongue carcinoma, and is associated with tumor differentiation and cisplatin resistance in tongue carcinoma."}, {"pubmed": 23696245, "text": "Downregulating topoisomerase IIbeta confers resistance specifically to mitoxantrone."}, {"pubmed": 23938298, "text": "Top2beta-DNA cleavage complexes arrest transcription elongation and induce a proteasomal degradation of Top2beta on DNA."}, {"pubmed": 24326092, "text": "There is an association between chemosensitivity and Pgp, GST-pi and Topo II expression in gastric cancer."}, {"pubmed": 24766193, "text": "These results are consistent with the hypothesis that etoposide quinone contributes to etoposide-related leukemogenesis through an interaction with topoisomerase IIbeta."}, {"pubmed": 24801450, "text": "This study demonstrated that top IIbeta overexpression is necessary for RA-induced neuronal differentiation."}, {"pubmed": 24808172, "text": "Proteolytic degradation of Top2 enables the processing of Top2.DNA and Top2.RNA covalent complexes by TDP2."}, {"pubmed": 25011107, "text": "Human cytomegalovirus IE1 exon 4 interacts with Topoisomerase IIbeta (TOPOIIbeta), whose activity is required for viral genome persistence and maintenance via binding to a cis-acting viral maintenance element."}, {"pubmed": 25217229, "text": "Data suggest that DNA topoisomerase IIbeta (topoIIbeta) silencing can significantly alter the gene expression pattern of genes involved in variety of biological processes and signal transduction pathways."}, {"pubmed": 25815590, "text": "Cinobufacini inhibited the proliferation of the HepG-2 cells induced apoptosis in a dose- and time-dependent manner and downregulated the mRNA and protein expression levels of TOPO I and TOPO II"}, {"pubmed": 26055322, "text": "A direct interaction between Ku70/86 and BRG1 brings together SWI/SNF remodeling capabilities and TOP2beta activity to enhance the transcriptional response to hormone stimulation."}, {"pubmed": 26612825, "text": "during early development, TOP2A is likely to have a role in cell proliferation, whereas TOP2B is expressed in post-mitotic cells and may be important in controlling expression of long genes even at this early stage."}, {"pubmed": 26876283, "text": "TopoIIbeta is involved in the cascade of coactivator complexes that are recruited to LTR for regulation of HIV-1 transcription."}, {"pubmed": 27582050, "text": "TOP2B is positioned to solve topological problems at diverse cis-regulatory elements and its occupancy is a highly ordered and prevalent feature of CTCF/cohesin binding sites that flank TADs."}, {"pubmed": 28087392, "text": "Data indicate that cortex involvement, lower World Health Organization grade and DNA topoisomerase II positivity were strong predictors for preoperative epileptic seizures."}, {"pubmed": 28102848, "text": "recent data point to a critical role of topoisomerase II beta (TOP2B), which is a primary target of anthracycline poisoning, in the pathophysiology of anthracycline-induced congestive heart failure ."}, {"pubmed": 28472494, "text": "The decatenation checkpoint is regulated, not only by topo IIalpha, as previously reported, but also by topo IIbeta. The decatenation checkpoint is most efficient when both isoforms are present. Deletion of most of the C-terminus of topo IIbeta, while preserving the nuclear localization signal, and mutation of Y656 in topo IIbeta inhibits the decatenation checkpoint and sensitivity to topo II-targeted drugs."}, {"pubmed": 28554742, "text": "our data primarily indicate that topoIIbeta can be used to estimate neuronal differentiation in medulloblastoma"}, {"pubmed": 28669856, "text": "The article discusses origin of topoisomerase II beta, its structure, activities reported in vitro and in vivo along with implications in cellular processes namely transcription, DNA repair, neuronal development, aging, HIV-infection and cancer. (Review)"}, {"pubmed": 28700616, "text": "These results explain why hTOPIIa and hTOPIIa are differentially affected by various poisons and demonstrate the utility of C. elegans in understanding the genetics of drug responses."}, {"pubmed": 30169847, "text": "We report here that both known type II topoisomerases Top2a and Top2b are present in mammalian mitochondria, with especially Top2b regulating the supercoiling state of mtDNA. Loss of Top2b or its inhibition by ciprofloxacin results in accumulation of positively supercoiled mtDNA, followed by cessation of mitochondrial transcription and replication initiation, causing depletion of mtDNA copy number."}, {"pubmed": 30216786, "text": "our findings suggest that E2F1-topoII beta signaling may play a role in regulation of cell cycle exit and neuronal differentiation."}, {"pubmed": 30318608, "text": "Topo-2beta may be part of activation/repression of protein complexes activated by epigenetic modifying agents, differentiating signals, and inducible locus."}, {"pubmed": 31090963, "text": "NEK5 interacts with topoisomerase IIbeta and is involved in the DNA damage response induced by etoposide."}, {"pubmed": 31106979, "text": "Doxorubicin-induced cardiotoxicity is maturation dependent due to the shift from topoisomerase IIalpha to IIbeta in human stem cell derived cardiomyocytes."}, {"pubmed": 31198993, "text": "TOP2B was found to play an important role in hearing development. The D1613H mutation of TOP2B co-segregated with autosomal-dominant nonsyndromic hearing loss in a Chinese family. The L721F, K1435del and D1613H mutations of TOP2B were detected in 66 sporadic cases, indicating that TOP2B could provide a novel marker in the diagnosis of deafness."}, {"pubmed": 31409799, "text": "Mutations in TOP2B are underlie the syndromic B-cell immunodeficiency."}, {"pubmed": 32128574, "text": "Topoisomerase 2beta mutation impairs early B-cell development."}, {"pubmed": 32218491, "text": "Association of immunophenotype with expression of topoisomerase II alpha and beta in adult acute myeloid leukemia."}, {"pubmed": 32535049, "text": "Mining topoisomerase isoforms in gastric cancer."}, {"pubmed": 32767399, "text": "Transcription of carbonyl reductase 1 is regulated by DNA topoisomerase II beta."}, {"pubmed": 33402057, "text": "Down regulation of DNA topoisomerase IIbeta exerts neurodegeneration like effect through Rho GTPases in cellular model of Parkinson's disease by Down regulating tyrosine hydroxylase."}, {"pubmed": 33563836, "text": "Topoisomerase 2beta Induces DNA Breaks To Regulate Human Papillomavirus Replication."}, {"pubmed": 33704596, "text": "Topoisomerase IIbeta immunoreactivity (IR) co-localizes with neuronal marker-IR but not glial fibrillary acidic protein-IR in GLI3-positive medulloblastomas: an immunohistochemical analysis of 124 medulloblastomas from the Japan Children's Cancer Group."}, {"pubmed": 34610268, "text": "BRCA1-BARD1 regulates transcription through modulating topoisomerase IIbeta."}, {"pubmed": 35660158, "text": "A comprehensive structural analysis of the ATPase domain of human DNA topoisomerase II beta bound to AMPPNP, ADP, and the bisdioxopiperazine, ICRF193."}, {"pubmed": 35831557, "text": "TOP2B Is Required to Maintain the Adrenergic Neural Phenotype and for ATRA-Induced Differentiation of SH-SY5Y Neuroblastoma Cells."}, {"pubmed": 36410793, "text": "Effects of hsa-miR-9-3p and hsa-miR-9-5p on Topoisomerase IIbeta Expression in Human Leukemia K562 Cells with Acquired Resistance to Etoposide."}, {"pubmed": 36766705, "text": "Taspase1 Facilitates Topoisomerase IIbeta-Mediated DNA Double-Strand Breaks Driving Estrogen-Induced Transcription."}, {"pubmed": 37068767, "text": "Revisiting TOP2B-related phenotypes: Three new cases and literature review."}, {"pubmed": 37834253, "text": "To Break or Not to Break: The Role of TOP2B in Transcription."}, {"pubmed": 38038260, "text": "Using energy to go downhill-a genoprotective role for ATPase activity in DNA topoisomerase II."}, {"pubmed": 38240344, "text": "DNA-PKcs-mediated transcriptional regulation of TOP2B drives chemoresistance in acute myeloid leukemia."}, {"pubmed": 38263255, "text": "MDM2 provides TOP2 poison resistance by promoting proteolysis of TOP2betacc in a p53-independent manner."}], "genomic_pos": {"chr": "3", "end": 25664909, "ensemblgene": "ENSG00000077097", "start": 25597978, "strand": -1}, "genomic_pos_hg19": {"chr": "3", "end": 25706398, "start": 25639475, "strand": -1}, "go": {"BP": [{"evidence": "IBA", "gocategory": "BP", "id": "GO:0000712", "qualifier": "involved_in", "term": "resolution of meiotic recombination intermediates"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0000819", "qualifier": "involved_in", "term": "sister chromatid segregation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001764", "qualifier": "involved_in", "term": "neuron migration"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0006265", "pubmed": 10684600, "qualifier": "involved_in", "term": "DNA topological change"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007409", "qualifier": "involved_in", "term": "axonogenesis"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0030183", "pubmed": [31409799, 32128574], "qualifier": "involved_in", "term": "B cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030900", "qualifier": "involved_in", "term": "forebrain development"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0045870", "pubmed": 16712776, "qualifier": "involved_in", "term": "positive regulation of single stranded viral RNA replication via double stranded DNA intermediate"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0070301", "qualifier": "involved_in", "term": "cellular response to hydrogen peroxide"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071318", "qualifier": "involved_in", "term": "cellular response to ATP"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0090398", "qualifier": "involved_in", "term": "cellular senescence"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:2001034", "qualifier": "involved_in", "term": "positive regulation of double-strand break repair via nonhomologous end joining"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0000792", "pubmed": 9049244, "qualifier": "part_of", "term": "heterochromatin"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005634", "qualifier": "is_active_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": [9049244, 9155056, 17567603], "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005654", "pubmed": 9049244, "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005654", "qualifier": "located_in", "term": "nucleoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005730", "pubmed": 9049244, "qualifier": "NOT located_in", "term": "nucleolus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005730", "pubmed": [8299728, 9155056], "qualifier": "located_in", "term": "nucleolus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "pubmed": 9049244, "qualifier": "located_in", "term": "cytosol"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:1990904", "qualifier": "part_of", "term": "ribonucleoprotein complex"}], "MF": [{"category": "MF", "evidence": "IEA", "id": "GO:0003677", "qualifier": "enables", "term": "DNA binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003682", "pubmed": 9049244, "qualifier": "enables", "term": "chromatin binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0003918", "pubmed": 10684600, "qualifier": "enables", "term": "DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0003918", "pubmed": [31409799, 32128574], "qualifier": "enables", "term": "DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [10473615, 10666337, 11062478, 11136718, 16611985, 17567603], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005524", "qualifier": "enables", "term": "ATP binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0043021", "qualifier": "enables", "term": "ribonucleoprotein complex binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046872", "qualifier": "enables", "term": "metal ion binding"}]}, "homologene": {"genes": [[3702, 821972], [4530, 4330426], [4896, 2540541], [4932, 855636], [5141, 3878536], [7955, 569877], [8364, 779457], [9031, 395966], [9544, 677709], [9598, 460232], [9606, 7155], [9615, 477044], [9913, 282097], [10090, 21974], [10116, 361100], [28985, 2892516], [33169, 4621483], [318829, 2684328]], "id": 134711}, "interpro": [{"desc": "DNA topoisomerase II, eukaryotic-type", "id": "IPR001154", "short_desc": "TopoII_euk"}, {"desc": "DNA topoisomerase, type IIA", "id": "IPR001241", "short_desc": "Topo_IIA"}, {"desc": "DNA topoisomerase, type IIA, domain A", "id": "IPR002205", "short_desc": "Topo_IIA_dom_A"}, {"desc": "Histidine kinase/HSP90-like ATPase", "id": "IPR003594", "short_desc": "HATPase_C"}, {"desc": "TOPRIM domain", "id": "IPR006171", "short_desc": "TOPRIM_domain"}, {"desc": "DNA topoisomerase, type IIA, subunit B, domain 2", "id": "IPR013506", "short_desc": "Topo_IIA_bsu_dom2"}, {"desc": "DNA topoisomerase, type IIA, alpha-helical domain superfamily", "id": "IPR013757", "short_desc": "Topo_IIA_A_a_sf"}, {"desc": "DNA topoisomerase, type IIA, domain A, alpha-beta", "id": "IPR013758", "short_desc": "Topo_IIA_A/C_ab"}, {"desc": "DNA topoisomerase, type IIA, subunit B, C-terminal", "id": "IPR013759", "short_desc": "Topo_IIA_B_C"}, {"desc": "DNA topoisomerase, type IIA-like domain superfamily", "id": "IPR013760", "short_desc": "Topo_IIA-like_dom_sf"}, {"desc": "Small ribosomal subunit protein uS5 domain 2-type fold, subgroup", "id": "IPR014721", "short_desc": "Ribsml_uS5_D2-typ_fold_subgr"}, {"desc": "DNA topoisomerase, type IIA, conserved site", "id": "IPR018522", "short_desc": "TopoIIA_CS"}, {"desc": "Ribosomal protein uS5 domain 2-type superfamily", "id": "IPR020568", "short_desc": "Ribosomal_Su5_D2-typ_SF"}, {"desc": "C-terminal associated domain of TOPRIM", "id": "IPR031660", "short_desc": "TOPRIM_C"}, {"desc": "DNA topoisomerase 2, TOPRIM domain", "id": "IPR034157", "short_desc": "TOPRIM_TopoII"}, {"desc": "Histidine kinase/HSP90-like ATPase superfamily", "id": "IPR036890", "short_desc": "HATPase_C_sf"}, {"desc": "DTHCT", "id": "IPR012542", "short_desc": "DTHCT"}], "ipi": ["IPI00027280", "IPI00217709", "IPI00925477", "IPI01014228"], "map_location": "3p24.2", "name": "DNA topoisomerase II beta", "other_names": ["DNA topoisomerase 2-beta", "DNA topoisomerase II, 180 kD", "DNA topoisomerase II, beta isozyme", "U937 associated antigen", "antigen MLAA-44", "topo II beta", "topoisomerase (DNA) II beta 180kDa", "topoisomerase II beta", "topoisomerase IIb"], "pantherdb": {"HGNC": "11990", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "98791", "ortholog_type": "LDO", "panther_family": "PTHR10169", "taxid": 10090, "uniprot_kb": "Q64511"}, {"Gene": "TOP2B", "ortholog_type": "O", "panther_family": "PTHR10169", "taxid": 9031, "uniprot_kb": "O42131"}, {"Ensembl": "ENSGALG00000011300", "ortholog_type": "LDO", "panther_family": "PTHR10169", "taxid": 9031, "uniprot_kb": "A0A3Q2U225"}, {"ZFIN": "ZDB-GENE-041008-136", "ortholog_type": "LDO", "panther_family": "PTHR10169", "taxid": 7955, "uniprot_kb": "Q1LUT2"}, {"WormBase": "WBGene00019884", "ortholog_type": "O", "panther_family": "PTHR10169", "taxid": 6239, "uniprot_kb": "P34534"}, {"WormBase": "WBGene00022854", "ortholog_type": "O", "panther_family": "PTHR10169", "taxid": 6239, "uniprot_kb": "G5ECQ8"}, {"WormBase": "WBGene00010785", "ortholog_type": "O", "panther_family": "PTHR10169", "taxid": 6239, "uniprot_kb": "Q23670"}, {"FlyBase": "FBgn0284220", "ortholog_type": "O", "panther_family": "PTHR10169", "taxid": 7227, "uniprot_kb": "P15348"}, {"SGD": "S000005032", "ortholog_type": "O", "panther_family": "PTHR10169", "taxid": 4932, "uniprot_kb": "P06786"}, {"PomBase": "SPBC1A4.03c", "ortholog_type": "O", "panther_family": "PTHR10169", "taxid": 4896, "uniprot_kb": "P08096"}, {"dictyBase": "DDB_G0279737", "ortholog_type": "O", "panther_family": "PTHR10169", "taxid": 352472, "uniprot_kb": "P90520"}, {"dictyBase": "DDB_G0270418", "ortholog_type": "O", "panther_family": "PTHR10169", "taxid": 352472, "uniprot_kb": "Q55BP5"}, {"TAIR": "2076201", "ortholog_type": "O", "panther_family": "PTHR10169", "taxid": 3702, "uniprot_kb": "P30182"}], "uniprot_kb": "Q02880"}, "pathway": {"reactome": [{"id": "R-HSA-2990846", "name": "SUMOylation"}, {"id": "R-HSA-3108232", "name": "SUMO E3 ligases SUMOylate target proteins"}, {"id": "R-HSA-392499", "name": "Metabolism of proteins"}, {"id": "R-HSA-4615885", "name": "SUMOylation of DNA replication proteins"}, {"id": "R-HSA-597592", "name": "Post-translational protein modification"}], "smpdb": [{"id": "SMP00442", "name": "Etoposide Action Pathway"}, {"id": "SMP00601", "name": "Etoposide Metabolism Pathway"}]}, "pdb": ["3QX3", "4G0U", "4G0V", "4G0W", "4J3N", "5GWI", "5GWJ", "5ZAD", "5ZEN", "5ZQF", "5ZRF", "7QFN", "7QFO", "7YQ8", "7ZBG"], "pfam": ["PF00204", "PF00521", "PF01751", "PF02518", "PF16898", "PF08070"], "pharmgkb": "PA36672", "pharos": {"target_id": 2430, "tdl": "Tclin"}, "pir": "S26730", "prosite": "PS50880", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF229413", "relationship": "is"}, {"id": "GNF257463", "relationship": "is"}, {"id": "GNF257464", "relationship": "is"}, {"id": "GNF257465", "relationship": "is"}, {"id": "GNF257466", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF038482", "relationship": "similar to"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF091534", "relationship": "is"}, {"id": "GNF091535", "relationship": "is"}, {"id": "GNF091536", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF051685", "relationship": "is"}, {"id": "GNF056451", "relationship": "is"}, {"id": "GNF061212", "relationship": "is"}, {"id": "GNF078673", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF067037", "relationship": "is"}, {"id": "GNF067038", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF094553", "relationship": "is"}, {"id": "GNF134210", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000003.12", "NC_060927.1", "NG_052961.1"], "protein": ["NP_001059.2", "NP_001317629.1", "XP_011532359.1", "XP_047304777.1", "XP_047304778.1", "XP_054203683.1", "XP_054203684.1", "XP_054203685.1"], "rna": ["NM_001068.3", "NM_001330700.2", "XM_011534057.4", "XM_047448821.1", "XM_047448822.1", "XM_054347708.1", "XM_054347709.1", "XM_054347710.1"], "translation": [{"protein": "NP_001059.2", "rna": "NM_001068.3"}, {"protein": "XP_054203685.1", "rna": "XM_054347710.1"}, {"protein": "XP_047304777.1", "rna": "XM_047448821.1"}, {"protein": "NP_001317629.1", "rna": "NM_001330700.2"}, {"protein": "XP_011532359.1", "rna": "XM_011534057.4"}, {"protein": "XP_054203683.1", "rna": "XM_054347708.1"}, {"protein": "XP_047304778.1", "rna": "XM_047448822.1"}, {"protein": "XP_054203684.1", "rna": "XM_054347709.1"}]}, "reporter": {"HG-U133_Plus_2": "211987_at", "HG-U95Av2": ["1581_s_at", "36571_at"], "HTA-2_0": "TC03001247.hg.1", "HuEx-1_0": "2666478", "HuGene-1_1": "8085815", "HuGene-2_1": ["16951601", "16951644", "17119370"]}, "summary": "This gene encodes a DNA topoisomerase, an enzyme that controls and alters the topologic states of DNA during transcription. This nuclear enzyme is involved in processes such as chromosome condensation, chromatid separation, and the relief of torsional stress that occurs during DNA transcription and replication. It catalyzes the transient breaking and rejoining of two strands of duplex DNA which allows the strands to pass through one another, thus altering the topology of DNA. Two forms of this enzyme exist as likely products of a gene duplication event. The gene encoding this form, beta, is localized to chromosome 3 and the alpha form is localized to chromosome 17. The gene encoding this enzyme functions as the target for several anticancer agents and a variety of mutations in this gene have been associated with the development of drug resistance. Reduced activity of this enzyme may also play a role in ataxia-telangiectasia. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2016].", "symbol": "TOP2B", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1336658"}, "unigene": "Hs.475733", "uniprot": {"Swiss-Prot": "Q02880", "TrEMBL": ["H7BZ82", "Q59H80", "A0A8V8TN33", "E9PCY5", "A0A8V8TP20", "A0A8V8TPE3"]}, "wikipedia": {"url_stub": "TOP2B"}}